Suspension Cell Virus Production Without Centrifugation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing lentiviral vectors in adherent cell lines are costly and hinder process scalability and reproducibility, requiring large amounts of GMP-grade plasmids and involving high shear forces that lower cell quality and increase contamination risks.
Innovation Solution
A method for producing enveloped viruses in suspension cell cultures using a tetracycline-suppressible gene expression system, where tetracycline concentration is reduced by dilution or acoustic standing waves to induce viral production, avoiding centrifugation and manual steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If centrifugation is used to remove tetracycline from suspension cell culture, then viral production is induced, but cell quality is lowered and contamination risks increase
Solution Approach 1:
The patent replaces the mechanical centrifugation system with a chemical substitution system. Instead of using centrifugal force to remove tetracycline, the invention introduces a tetracycline-free cell culture medium that allows viral production to be induced through media exchange alone, eliminating the need for mechanical processing that damages cells.
Solution Approach 2:
The patent uses a tetracycline-free cell culture medium as an intermediary substance to facilitate viral production. This medium serves as a bridge that enables the transition from tetracycline-suppressed state to viral production state without requiring direct mechanical intervention on the cells.
2Productivity
If centrifugation and manual steps are used to reduce tetracycline concentration, then viral production is induced, but contamination risks increase
Solution Approach 1:
The patent replaces manual mechanical operations with an automated media exchange system. The viral production induction is achieved through automated addition of tetracycline-free medium, eliminating open manual steps that create contamination pathways.
Solution Approach 2:
The patent maintains continuous closed-system operation throughout the viral production induction process. The media exchange is performed without opening the system to the external environment, ensuring continuous protection against contamination while maintaining productive viral induction.
3Productivity
If transient transfection of adherent cell lines is used to produce lentiviruses, then viral production is achieved, but process scalability and reproducibility are hampered
Solution Approach 1:
The patent inverts the conventional approach by using suspension cell lines instead of adherent cell lines, and stable cell lines instead of transiently transfected cells. This inversion enables viral production in a format that is inherently more scalable and reproducible, as suspension cultures can be more easily expanded and maintained with greater consistency.
Solution Approach 2:
The patent performs preliminary action by establishing stable cell lines with integrated tetracycline-responsive viral production systems before production. This advance preparation of genetically modified suspension cell lines creates a reproducible foundation that can be scaled up without the variability associated with transient transfection.
4Productivity
If large amounts of GMP-grade plasmids are used in adherent cell line production, then viral production is achieved, but production costs increase
Solution Approach 1:
The patent performs preliminary action by permanently integrating viral production capabilities into the genome of suspension cell lines during cell line development. This eliminates the need for large amounts of plasmid DNA during each production run, as the production machinery is already built into the cells and can be induced with simple media exchange.
Solution Approach 2:
The patent changes the fundamental parameter of cell line type from adherent to suspension, and from transiently transfected to stably modified. This parameter change fundamentally alters the production economics, eliminating the recurring cost of GMP-grade plasmids while maintaining high viral production capability through inducible expression systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances viral production efficiency, maintains cell quality, reduces contamination risks, and improves scalability and reproducibility, achieving high viral infectious titer yields suitable for commercial scale and regulatory compliance.
Implementation Method 1
retaining the suspension cell line cells using an acoustic standing wave
Data Source
AI summary
The present disclosure relates to methods of producing an enveloped virus in a suspension cell culture, the method comprising culturing a suspension cell line expressing a tetracycline-suppressible gene expression system in a cell culture medium. The present disclosure also relates to stable producer cell clones capable of producing an enveloped virus in a suspension cell culture.